首页> 外文期刊>BMC Complementary and Alternative Medicine >Jian-Pi-Yi-Shen Formula ameliorates chronic kidney disease: involvement of mitochondrial quality control network
【24h】

Jian-Pi-Yi-Shen Formula ameliorates chronic kidney disease: involvement of mitochondrial quality control network

机译:建 - 益氏配方改善慢性肾脏疾病:线粒体质量控制网络的参与

获取原文
获取外文期刊封面目录资料

摘要

Jian-Pi-Yi-Shen Formula (JPYSF), a Chinese herbal decoction with the efficacies of 'fortify the spleen and tonify the kidney' and 'activate blood and resolve stasis', is effective for the treatment of chronic kidney disease in clinic. However, the underlying mechanism remains unclear. The aim of this study was to investigate the therapeutic effects and possible mechanisms of JPYSF on retarding chronic kidney disease progression in 5/6 nephrectomized (5/6 Nx) rats. Perindopril (4?mg/kg/d) and JPYSF (2.72?g/kg/d) were administrated by gavage to 5/6 Nx rats daily for 6?weeks. The therapeutic effects of JPYSF were evaluated by renal function, pathological injury, and fibrosis. The protein levels associated with mitochondrial quality control network were measured by Western blot and immunofluorescence analysis. 5/6 Nx rats showed obvious decline in renal function as evidenced by increased serum creatinine, blood urea nitrogen, and urinary protein excretion, and significant injury in kidney structure as evidenced by glomerular hypertrophy, tubular atrophy, and interstitial fibrosis. Administration of JPYSF for 6 weeks could improve renal function and ameliorate kidney structure injury in 5/6 Nx rats. Furthermore, the remnant kidneys of 5/6 Nx rats showed unbalanced mitochondrial quality control network manifested as decreased mitochondrial biogenesis, fusion, and mitophagy, and increased mitochondrial fission. Treatment of JPYSF could restore aforesaid aspects of mitochondrial quality control network. These results indicate that JPYSF can notably ameliorate 5/6 Nx-induced chronic kidney disease, which may be related with modulation of mitochondrial quality control network.
机译:j益沉甲式(JPYSF),中国草药汤与“强化脾脏和调整肾脏”和“激活血液和解决瘀滞”的疗效,对诊所治疗慢性肾病有效。但是,潜在机制仍然不清楚。本研究的目的是探讨JPYSF在延缓慢性肾病进展中的治疗效果和可能的机制,在5/6肾脏(5/6 NX)大鼠中。 Perindopril(4?mg / kg / d)和Jpysf(2.72 k / kg / d)每天给予5/6 nx大鼠6?周。通过肾功能,病理损伤和纤维化评估JPYSF的治疗效果。通过蛋白质印迹和免疫荧光分析测量与线粒体质量控制网络相关的蛋白质水平。 5/6 NX大鼠表现出肾功能明显下降,如血清肌酐,血液尿素氮和尿蛋白排泄,肾脏结构的显着损伤,如肾小球肥大,管状萎缩和间质纤维化的显着损伤。 JPYSF施用6周可提高肾功能和5/6 NX大鼠的肾脏结构损伤。此外,5/6 NX大鼠的残余肾脏显示出不平衡的线粒体质量控制网络,表现为下降的线粒体生物发生,融合和乳化物,并增加线粒体裂变。 JPYSF治疗可以恢复线粒体质量控制网络的前述方面。这些结果表明JPYSF可以显着改善5/6 NX诱导的慢性肾病,这可能与线粒体质量控制网络的调节有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号